Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 2,344 startups that have raised more than $5 billion in funding, generated more than $2.7 billion in revenue, and created more than 126,000 total jobs. 

Our startups

Be inspired. Search our startups.


Cancer cells grown in our 3D models secrete exosomes enriched with tumor-specific cargo. We use an Omics screening approach to identify novel biomarkers in these exosomes. Our first proprietary biomarker for prostate cancer outperformed PSA, the current clinical standard, in a retrospective clinical analysis. Now we are developing a reagent kit for the prostate cancer test to be administered at point-of-care, and expanding discovery efforts to pancreatic and ovarian cancer as new indications.
We use a proprietary tool to identify exosome cargo linked to cancer metastasis and develop 'biomarker hits' into liquid biopsy diagnostics

Connect with CellSpring


2019 Platinum Switzerland

Sub industry



MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.